Approval · Notice of Compliance 27683 · 2022
FLUTAMIDE: Notice of Compliance 27683
Issued March 1, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27683
- Date
- March 1, 2022
- Company
- AA Pharma Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph to align with the 2020 PM Master Template.
- Canadian reference product
- EUFLEX (Schering Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FLUTAMIDE | Not yet assigned | — |
Medicinal ingredients
- FLUTAMIDE 250 MG per TAB